We would love to hear your thoughts about our site and services, please take our survey here.
From LinkedIn:
We are very pleased to announce that our BlackOak Alpha Growth Fund returned 1.16% in February, bringing the total returns since the funds inception to 29.98%.
The Fund has achieved positive returns in 41 out 42 months, with no negative returns and only one month which returned 0% growth. This is a great result and shows that it's possible to achieve equity like returns with bond like volatility.
Main market, not AIM but agree with the need for more comms.
My expectation is that we will see a significant amount of news on the back of the full year accounts when they're released. An Operational Update for the four company elements and a forward looking update on this years targets/objectives as a minimum.
Indeed. Frustrating. Guess there's a lot of opportunities out there in the market right now so not surprising there's some selling.
Large number of shares exchanged hands recently at 2.7p so wouldn't be surprised to see some buying volume kick in now. As always with Alpha it doesn't take large volumes to move the share price in either direction.
These had a exercise price of 2p as per the Prospectus:
"On 15 March 2021, the Company entered into a warrant instrument pursuant to which the Company issued
to Jarvis Investment Management Limited (as nominee for Pello) warrants over 18,750,000 Ordinary
Shares representing 10 per cent. of the Placing Shares issued to placees in the Placing. The warrants are
exercisable for a period of three years at 2 pence per share. "
After these all that's left is the main 187.5m block with 3p strike price.
Broker note had BOAGF AUM at "more than $45m AUM" a few weeks ago so we already know the value. Then the RNS this week has the performance figures:
--
BlackOak Alpha Growth Fund returns
The Company is pleased to report that the BlackOak Alpha Growth Fund returned 7.20% during 2022. During this period it reported positive returns every month and won multiple awards from Barclay Hedge for its performance.
Since inception in September 2019 up until end December 2022, the fund has produced returns of over 27% compared with the FTSE 100 which has only increased by circa 2% over the same period. Over the same period the fund recorded positive returns in all but one month with zero negative returns versus the much more volatile FTSE100 which recorded losses in 5 months.
--
So we know that the Hurdle Rate has been reached even for investments that were only made at the start of last year and it looks like BOAGF may have had some redemptions which isn't surprising I guess given market conditions over the past 12 months.
What kind of thing you thinking? I know the team have been meeting with a significant number of city investors, Family Offices and UHNWIs marketing the company (both its products but also as a direct investment opportunity) which is great to hear. As per David H's comments it's clear they're finding a receptive audience.
You thinking the mass marketing stuff like the videos etc that started last summer? I guess the counter view is that things like that are unlikely to substantially move the share price in the current market and instead it will be the financials/revenue numbers, deal flow and new money coming in from those new substantial investors that will eventually trigger a re-rate. Definitely share the frustrations though. Feels like the market is lagging the growth rate and potential of the company currently. If we were sat at 4-5p it would feel quite different.
Nice and well written 2022 Recap RNS from the company today and its amazing, when it's all listed in one place, to see how much was achieved last year. Whilst there's nothing significantly new in the RNS it's handy for new investors to see it all in one place rather than having to trawl through. Putting myself in their shoes, I can't think of a single company I've invested in over the years that would have delivered so much change in one year.
Next update will be the FY2022 accounts which, based on the broker note, will show the company near or at breakeven. I'm also hopeful we will see the company set out their next phase of growth targets as they have already delivered all of the ones we discussed at last years AGM.
BTW - If I were a betting man I'd guess that the company will issue a consolidated 'package' of good news items together.
By this time last year we had already received the BOAGF Year End figures plus an Operational Update with the Year End update coming later in the year because of the Covid extension all listed companies were given. My suspicion is that we will see all these items delivered together (plus maybe even an update on another acquisition...) and we already know what ballpark the figures will be in from the Broker Note. My view is that these will trigger the next rerate we've been waiting for.
All quiet. Must admit I'm surprised our background buyer has paused, got what they wanted for now or is holding themselves to a 3p limit.
Based on the estimates in the Broker Note the FY22 results will show that the company is now either at, or pretty much at, breakeven with revenue £4.15m+. AUM will be c$700m+ following the acquisitions and last years organic growth. Plus there was also some very deliberate sounding wording around the scale of some of the next potential acquisition targets being considered so I wouldn't be surprised if one or more of these are nearly ready to be announced.
My expectation is that these combined will be enough to re-rate us again up towards 4p so I'm a bit surprised the buyer hasn't continued to take the opportunity to acquire in the low 3.x's. Maybe I'm wrong and the breakeven milestone won't be that big a deal and the growth potential is more important. Guess we'll see.
Great to hear and not surprised the company is ramping up its sales/marketing activity to accelerate organic growth. With the four cornerstones in place now - PLAC, BOAGF, AAACX and AILAC - plus Chad joining they should have everything they need to accelerate those inflows.
Also seeing quite a tick up of media coverage around Life Settlements as an investment class for the wider equity market reasons you mention which can only help too.
IMO - in a word, yes.
$2B AUM, 30bps to 50bps policy admin charge (as the lowest of the revenue streams to the company has), some guesstimate BAU opex costs, a conservative P/E of 10, no further dilution and I get to 10-17p per share. Then if the company becomes an acquisition target, 1.5x-2x that.
However, based on the broker note it sounds like $2B AUM is very conservative and will probably be exceeded, we will see some warrants exercised along the way to fund acquisitions but equally the above doesn't include any of the fund performance payments etc.